Fototerapia e fotochemioterapia

0
2018

Dermakos 2018;2:51-60

BIBLIOGRAFIA

  1. Johnson BE. Phototherapy. In: the physiology and pathophysiology of the skin (Jarett A, ed.). London: Academic Press, 1984; 2607-19
  2. Krutmann J, Morita A. Mechanisms of ultraviolet (UV) B and UVA phototherapy. J Invest Dermatolo Symp Proc 1999; 4: 70-2
  3. Walters IB; Ozawa M, Carindale I et al. Narrowband (312 nm) UVB suppresses inteferon g and inteleukin (IL) 12 and increases IL 4 transcripts: differential. Regulation of cytokines at the single cell level. Arch Dermatol 2003; 139: 155-61
  4. Guckian M, Jones CD, Vestey JP et al. Immunomodulation at the initiation of phototherapy and photochemiotherapy. Phototdermato Photoimmunol Photomed 1995; 11: 163-9
  5. El-Ghorr AA, Norval M, Lappin MB, Crosby JC. The effect of chronic low dose UVB radiation on Langerhans cells, sunburn cells, urocanic acid isomers, contact hypersensitivity and serum immunoglobulins in mice. Photochem Photobiol 1995; 62: 326-32
  6. Jones CD, Guckian M, El-Ghorr AA et al. Effects of phototherapy on the production of cytokines by peripheral blood mononuclear cells and on systemic antibody responses in patients with psoriasis. Photodermatol Photoimmunol Photomed 1996; 12: 204-10
  7. El-Ghorr AA, Norval M. Biological effects of narrow band (311 nm TL01) UVB irradiation: a review. J Photochem Photobiol B Biol 1997; 38: 99-106
  8. Gordon PM, Diffey BL, Matthews JNS, Farr PM. A randomised comparison of narrow band TL-01 phototherapy and PUVA photochemiotherapy for psoriasis. J Am Acad Dermatol 1999; 41: 728-32
  9. Dawe RS, Cameron H, Yule S et al. UVB phototherapy clears psoriasis through local effects. Arch Dermatol 2002; 138: 1071-6
  10. Ibbotson SH, Bilsland D, Cox NH, et al. An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report. Br J Dermatol 2004; 151: 283-97
  11. George SA, Bilsland DJ, Johnson BE, Ferguson J. Narrow band (TL-01) UVB air conditioned phototherapy for chronic severe adult atopic dermatitis. Br J Dermatol 1993; 128: 49-56
  12. Bilsland D, George SA, Gibbs NK et al. A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol 1993; 129: 708-12
  13. Dawe R. An overview of the cutaneous porphyrias. . F1000Res 2017; 6: 1906. doi: 10.12688/f1000research.10101.1.
  14. Narrowband ultraviolet B phototherapy in erythropoietic propoporphyria: case series. Br J Dermatol 2014; 170: 987-8
  15. Tjioe M, Gerritsen MJP, Juhlin L, van De Kerkhof PCM. Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol 2002; 82: 369-72
  16. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42: 245-53
  17. Patel DC, Evans AV, Hawk JLM. Topical pseudocatalase mousse and narrow band UVB phototherapy is not effective for vitiligo: an open, single-centre study. Clin Exp Dermatol 2002; 27: 641-4
  18. Pacifico A, Leone G.Photo(chemo)therapy for vitiligo.  Photodermatol Photoimmunol Photomed 2011; 27: 261-77
  19. Whitton ME, Pinart M, Batchelor J, Leonardi Bee J, Gonzalez U, Jiyad Z, Eleftheriadou V, Ezedine K.Interventions for vitiligo.  Cochrane Database of Systematic Reviews 2015; Issue 2. Art No CD003263
  20. Hofer A, Cerroni L, Kerl H, Wolf P. Narrowband (311 nm) UVB therapy for small plaque parapsoriasis and early stage mycosis fungoides. Arch Dermatol 1999; 135: 1377-80
  21. Clark C, Dawe RS, Evans AT et al. Narrow band TL-01 phototherapy for patch stage mycosis fungoides. Arch Dermatol 2000; 136: 748-52
  22. Gathers RC, Scherschun L, Malick F et al. Narrowband UVB phototherapy for early stage mycosis fungoides. J Am Acad Dermatol 2002; 47: 191-7
  23. Diederen PVMM, van Weelden H, Sanders CJG et al. Narrowband UVB and psoralen UVA in the treatment of early stage mycosis fungoides: a retrospective study. J Am Acad Dermartol 2003; 48: 215-19
  24. Das S, Lloyd JJ, Farr PM. Similar dose- response and persistence of erythema with broad band and narrow band ultraviolet B lamps. J Invest Dermatol 2001; 117: 1318-21
  25. George SA, Ferguson J. Lesional blistering following narrow band (TL-01) UVB phototherapy for psoriasis: a report of four cases. Br J Dermatol 1992; 127: 445-6
  26. Khoo L, Asawanonda P, Grevelink SA, Taylor CR. Narrow band UVB associated lesional blister in pityriasis rubra pilaris. J Am Acad Dermatol 1999; 41: 803-4
  27. Goodwin RG, Finlay AY, Anstey AV. Vitiligo following narrow band TL-01 phototherapy for psoriasis. Br J Dermatol 2001; 144: 1264-5
  28. Young AR. Carcinogenicity of UVB phototherapy assessed. Lancet 1995; 345: 1431-2
  29. Spencer JM, Hadi SM. The excimer lasers. J Drugs Dermatol 2004; 3: 522-5
  30. Bianchi B, Campolmi P, Mavilia L, Danesi A, Rossi R, Cappugi P. Monochromatic excimer light (308 nm): an immunohistochemical study of cutaneous T cells and apoptosis related molecules in psoriasis. J Eur Acad Dermatol Venereol 2003; 17: 408-13
  31. Gerber W, Arheilger B, Ha TA, Hermann J, Ockenfels HM. Ultraviolet B 308 nm excimer laser treatment of psoriasis: a new phototerapeutic approach. Br J Dermatol 2003; 149: 1250-8
  32. Roelandts R. Photo(chemo)therapy for vitiligo. Photodermatol Photoimmunol Photomed 2003; 19: 1-4
  33. Leone G, Iacovelli P, Paro Vidolin A, Picardo M. Monochromatic excimer light 308 nm in the treatment of vitiligo: a pilot study. J Eur Acad Dermatol 2003; 17: 531-7
  34. Mori M, Campolmi P, Mavilia L, Rossi R, Cappugi P, Pimpinelli N. Monochromatic excimer light (308 nm) in patch stage IA mycosis fungoides. J Am Acad Dermatol 2004; 50: 943-5
  35. Aubin F, Vigan M, Puzenat E, et al. Evaluation of a novel 308 nm monochromatic excimer light delivery system in dermatology: a pilot study in different chronic localized dermatoses. Br J Dermatol 2005; 152: 99-103
  36. Godar DE. UVA1 radiation triggers two different final apoptotic pathways. J Invest Dermatol 1999; 112: 3-12
  37. Morita A, Werfel T, Stege H et al. Evidence that singlet oxygen-induced human T helper cell apoptosis in the basic mechanism of ultraviolet A radiation phototherapy. J Exp Med 1997; 186: 1763-68
  38. Mang R, Krutmann J. UVA1 phototherapy. Photomed Photoimmunol Photodermatol 2005; 21: 103-8
  39. Krutmann J, Diepgen TL, Luger TA, et al. High dose UVA1 therapy for atopic dermatitis: results of a multicentric trial. J Am Acad Dermatol 1998; 38: 589-93
  40. Legat FJ, Hofer A, Brabeck E, Quehenberger F, Kerl H, Wolf P. Narrowband UVB vs medium dose UVA1 phototherapy in chronic atopic dermatitis. Arch Dermatol 2003; 139: 223-4
  41. Morita A, Krutmann J. Ultraviolet A radiation induced apoptosis. Methods Enzymol 2000; 319: 302-9
  42. Plettenberg H, Stege H, Megahed M et al. Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T cell lymphoma. J Am Acad Dermatol 1999; 41: 47-50
  43. Zane C, Leali C, Airo P, De Panfilis G, Pinton PC. “High dose” UVA1 therapy of widespread claque-type, nodular and erythrodermic mycosis fungoides. J Am Acad Dermatol 2001; 44: 629-33
  44. Von Kobyletzki G, Dirschka T, Freitag M, Hoffman K, Altmeyer P. Ultraviolet A1 phototherapy improves the status of the skin in cutaneous T cell lymphoma. Br J Dermatol 1999; 140: 768-9
  45. Plettenberg H, Stege H, Megahed M, Krutmann J. UVA1 phototherapy versus PUVA photochemotherapy in the treatment of patients with cutaneous T cell lymphoma. Photodermatol Photoimmunol Photomed 2001; 17: 87
  46. Schmidt T, Abeck D, Boeck K, Mempel M, Ring J. UVA1 irradiation is effective in treatment of chronic versicular dyshidrotic hand eczema. Acta Derm Venereol 1998; 78: 318-9
  47. Polderman MC, Govaert JC, Le Cessie S, Pavel S. A double blind placebo controlled trial of UVA1 in the treatment of dyshidrotic eczema. Clin Exp Dermatol 2003; 28: 584-87
  48. Dawe RS. Ultraviolet A1 phototherapy. Br J Dermatol 2003; 148: 626-37
  49. Krutmann J, Stege H, Morita A. Ultraviolet A1 phototherapy: indications and mode of action. In: Krutmann J, Honigsmann H, Elmets CA, Bergstresser PR., eds. Phototherapy and photodiagnostic methods. Berlin: Springer-Verlag, 2001; 176-261
  50. Stege H, Schopf E, Ruzicka T, Krutmann J. High dose UVA1 for urticaria pigmentosa. Lancet 1996; 347: 64
  51. Gabello T, Mozzanti C, Sordi D, et al. Medium versus high dose ultraviolet A1 therapy for urticaria pigmentosa: a pilot study. J Am Acad Dermatol 2003; 49: 679-84
  52. Stege H, Berneburg M, Humke S, et al. High dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997; 36: 938-44
  53. Setlow RB, Grist E, Thompson K, Woodhead AD. Wavlenghts effective in induction of malignant melanoma. Proc Natl Acad Sci USA 1993; 90: 6666-70
  54. Wang SQ, Setlow R, Berwick M, et al. Ultraviolet A and melanoma: a review. J Am Acad Dermatol 2001; 44: 837-46
  55. Morison WL. Psoralen ultraviolet A therapy in 2004. Photodermatol Photoimmunol Photomed 2004; 20: 315-20
  56. Atherton DJ, Carabott F, Glover, MT, Hawk JLM. The role of psoralen photochemotherapy (PUVA) in the treatment of severe atopic eczema in adolescents. Br J Dermatol 1988; 118: 791-5
  57. Mackie RM, Foulds IS, Mc Millan EM, Nelson HM. Histological changes observed in the skin of patients with mycosis fungoides receiving photochemotherapy. Clin Exp Dermatol 1980; 5: 405-13
  58. Honigsman H, Brenner W, Rauschmeier W, Konrad K, Wolff K. Photochemotherapy for cutaneous T cell lymphoma. J Am Acad Dermatol 1984; 10: 238-245
  59. Parrish JA, LeVine MJ, Morison WL, Gonzalez E, Fitzpatrick TB. Comparison of PUVA and bets carotene in the treatment of polymorphous light eruption. Br J Dermatol 1979; 100: 187-191
  60. Morison WL, Marwaha S, Beck L. PUVA induced phototoxicity: incidences and causes. J Am Acad Dermatol 1997; 36: 183-5
  61. Schiener R, Gottlober P, Muller B, et al. PUVA-gel vs. PUVA-bath therapy for severe recalcitrant palmoplantar dermatoses. A randomized, single-blinded prospective study. Photodermatol Photoimmunol Photomed 2005; 21: 62-7

 

 

ARTICOLI CORRELATIALTRO DALL'AUTORE